ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0210

Themes in Patients’ Discordance with Provider’s Rheumatoid Arthritis Treatment Goals Relate to Patient Age, Gender, and Ethnicity

Kelly O'Neill1, Pamela Sinicrope2, Cynthia Crowson3, Kathryne Marks4, Rachel Giblon5, Elena Myasoedova2 and John Davis2, 1Rheumatoid Patient Foundation, Winter Springs, FL, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Eyota, MN, 4Brigham and Women's Hospital, Boston, MA, 5Mayo Clinic, Rochester, MN, Rochester, MN

Meeting: ACR Convergence 2022

Keywords: Outcome measures, Patient reported outcomes, Qualitative Research, rheumatoid arthritis, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: We previously reported on themes in patients’ treatment goals and their association with rheumatoid arthritis (RA) disease activity (DA) and aspects of rheumatology care, such as presence of a treatment plan or a shared goal discussion. This study aimed to gain insight into the reasons for discordance between patient and provider goals and to identify factors relating to the differences.

Methods: An anonymous online questionnaire was presented in 2019 on a secure survey system. U.S. residents ≥18 years of age with a self-reported RA diagnosis by a medical professional answered questions on demographics, DA, diagnosis and DMARD history, and RA treatment goals. Participants were asked how their providers’ RA treatment goals differed from their own.

Responses were assessed and coded thematically by a team using qualitative content analysis to identify how their goals differed from their providers’. Responses were also coded for strong emotion, poor communication, and difference in outcome expectation (high or low). Relationships between patient demographics and discordance with provider treatment goals were assessed using Chi-square tests for categorical variables and Kruskal-Wallis tests for continuous variables.

Results: The survey was completed by 907 RA patients (90% women) with 58 (11) yrs mean (SD) age and 11 (10) yrs since diagnosis. 82% (n=740) responded to the question “How do you think your healthcare provider’s treatment goals differ from your own goals?”. Of those, 53% (n=392) did not differ (“aligned” with their providers’ goals); 47% (n=348) reported one or more reasons they differed with respect to treatment goals (“non-aligned”). 14 reasons were identified, of which 7 were present in ≥10% of respondents. 10 reasons were grouped into 3 major themes: provider’s approach (PA), difference about treatment (DT), and lack of teamwork (LT). Overall patient-clinician discordance was higher in female patients (94% vs 87%, p< 0.001). Patients whose reason for discordance was LT were on average younger (p< 0.001), with an earlier mean age of diagnosis (p=0.001) and more likely to be Hispanic or Latino (10% vs 2%, p=0.002) compared to those who selected other reasons. Among non-aligned pairs, only 21% recall a shared goal discussion compared to 61% (p< 0.001).

Conclusion: This survey found a previously unreported rate of patient discordance with providers’ treatment goals and themes within patient accounts of that discordance which associate with patient age, gender, age at diagnosis, and other aspects of rheumatology care. Our study is unique in that reasons for patient discordance with provider’s goals are coded by common themes. Further research should seek greater insight to RA patient goals and their discordance with providers’ goals to investigate their significance in RA management.

Supporting image 1

Major and minor themes in patients’ discordance with providers’ RA treatment goals.

Supporting image 2

Frequencies of respondents who considered their goals not aligned with their provider’s and those who considered their goals aligned are divided by their response to Did your provider ask you about your RA treatment goals? on the left. On the right, frequencies of respondents who consider their providers to have lower outcome expectations and those whose provider’s have higher outcome expectations are also divided by their response to Did your provider ask you about your RA treatment goals?

Supporting image 3

The mean current age of respondents who considered their goals aligned with their provider’s and those who considered their goals not aligned are shown as well as the mean current age those whose discordance fell into the major themes of patient goal discordance. The mean current age is higher for those whose goals are aligned than those whose goals are not aligned with their provider


Disclosures: K. O'Neill, None; P. Sinicrope, None; C. Crowson, None; K. Marks, None; R. Giblon, None; E. Myasoedova, None; J. Davis, Pfizer.

To cite this abstract in AMA style:

O'Neill K, Sinicrope P, Crowson C, Marks K, Giblon R, Myasoedova E, Davis J. Themes in Patients’ Discordance with Provider’s Rheumatoid Arthritis Treatment Goals Relate to Patient Age, Gender, and Ethnicity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/themes-in-patients-discordance-with-providers-rheumatoid-arthritis-treatment-goals-relate-to-patient-age-gender-and-ethnicity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/themes-in-patients-discordance-with-providers-rheumatoid-arthritis-treatment-goals-relate-to-patient-age-gender-and-ethnicity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology